Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2012
08/01/2012EP1915994B1 Cyclic amine derivatives in combination with ppar regulators
08/01/2012EP1728864B1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy
08/01/2012EP1685159B1 Tim-3 polypeptides
08/01/2012EP1333853B1 Growth factor complex
08/01/2012EP1328653B1 Highly expressible genes
08/01/2012EP1181057B1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
08/01/2012CN1993333B Triazole derivative
08/01/2012CN102625813A Immunoglobulins with reduced aggregation
08/01/2012CN102625808A Spirocyclic amide derivatives
08/01/2012CN102618565A Cytotoxic T lymphocyte-associated antigen-4, (CTLA-4) fusion protein and preparation method and application thereof
08/01/2012CN102618425A Acer truncatum health-care wine and preparation method thereof
08/01/2012CN102618424A Acanthopanax brachypus life prolonging wine
08/01/2012CN102617893A Preparation and application of composition of panaxoside Rg3, ginseng polysaccharide and ganoderan
08/01/2012CN102617736A The new stable polyethylene glycol conjugate of interferon alpha, represented by one positional isomer
08/01/2012CN102617735A Antibodies against human IL17 and uses thereof
08/01/2012CN102617727A Thymalfasin compound and novel preparation method thereof
08/01/2012CN102617726A Recombinant horse allergen and mutant and preparation methods and applications thereof
08/01/2012CN102617723A Scorpion venom active peptides, preparation method thereof and application
08/01/2012CN102617719A Recombinant rice allergen and mutant and preparation methods and applications thereof
08/01/2012CN102617715A Recombinant fungus major allergen and mutant and preparation methods and applications thereof
08/01/2012CN102617632A Organic germanium complex, and preparation method and application thereof
08/01/2012CN102617599A Macrocyclic compound and application thereof
08/01/2012CN102617578A Imidazole derivative and medicine application thereof
08/01/2012CN102617470A Sinomenine 4-hydroxy etherification and esterification derivatives and preparation method and application thereof
08/01/2012CN102614523A Dexamethasone macromolecule prodrug and preparation method thereof
08/01/2012CN102614512A Multiple-variable dose regimen for treating TNFalpha-related disorders
08/01/2012CN102614442A Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis
08/01/2012CN102614429A Chinese herbal compound prescription able to induce biological red waves and its preparation
08/01/2012CN102614374A Chinese medicine tablet with immunoregulation and hypoglycemic effects and preparation method thereof
08/01/2012CN102614335A Method for preparing Huoxiang Zhengqi oral liquid
08/01/2012CN102614307A Preparation method of steroid saponin and flavone in flos daturae
08/01/2012CN102614305A Medicament for treating allergic purpura
08/01/2012CN102614263A Externally-applied medicament for treating acute eczema
08/01/2012CN102614231A Method for preparing cynomorium songaricum terpene and cynomorium songaricum polysaccharose from cynomorium songaricum
08/01/2012CN102614227A Ganoderma pill and processing method thereof
08/01/2012CN102614226A Application of cordyceps militaris link extract to preparation of health-care product or medicament for prompting leucocyte proliferation of breast cancer patient
08/01/2012CN102614215A Application of carbon monoxide molecules in inhibition on acute rejection after skin grafting
08/01/2012CN102614202A Mixture and liquid medicine or oral liquid for injection
08/01/2012CN102614194A Externally applied medicine for treating skin disease and application thereof
08/01/2012CN102614178A Loratadine combination drug orally disintegrating tablet and application thereof
08/01/2012CN102613713A Health-care bellyband
08/01/2012CN102613564A Ginseng, cartialgenous and lucid ganoderma capsule and preparation method of ginseng, cartialgenous and lucid ganoderma capsule
07/2012
07/31/2012US8232383 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
07/31/2012US8232260 In vivo production of small interfering RNAs that mediate gene silencing
07/31/2012US8232068 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
07/31/2012CA2494089C Polysaccharide of echinacea angustifolia
07/31/2012CA2489965C Pharmaceutical compositions for the treatment of diseases related to neurotrophines
07/31/2012CA2449999C Compounds and methods for the treatment or prevention of flavivirus infections
07/31/2012CA2404688C Nuclear factor .kappa.b inducing factor
07/31/2012CA2349217C Cancer-associated antigens and methods of their identification
07/31/2012CA2272407C Method and compositions for stimulation of an immune response to a differentiation antigen stimulated by an altered differentiation antigen
07/31/2012CA2223402C Methods of inhibiting phagocytosis
07/26/2012WO2012099805A2 Nanoparticle based immunological stimulation
07/26/2012WO2012099581A1 Dihydrofuropyrimidine compounds
07/26/2012WO2012099441A2 Immune response inhibiting composition containing stem cells expressing tryptophan metabolizing enzyme genes
07/26/2012WO2012099258A1 Therapeutic agent for alopecia
07/26/2012WO2012099093A1 Process for production of nk-cell-enriched blood preparation
07/26/2012WO2012098505A1 2-methoxy-pyridin-4-yl derivatives
07/26/2012WO2012098465A1 Pvrl4 (nectin 4) is a receptor for measles virus
07/26/2012WO2012098387A1 6, 7-ring-fused triazolo [4, 3 - b] pyridazine derivatives as pim inhibitors
07/26/2012WO2012097575A1 Method for preparing pharmaceutical composition for enhancing immunity and pharmaceutical composition prepared according to the method
07/26/2012WO2012013861A3 Use of blood group status iii
07/26/2012US20120190821 Recombinant soluble fc receptors
07/26/2012US20120190699 Pyridones useful as inhibitors of kinases
07/26/2012US20120190695 Phenyloxadiazole derivatives as pgds inhibitors
07/26/2012US20120190691 Pharmaceutical compositions for treatment of respiratory and inflammatory diseases
07/26/2012US20120190689 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist
07/26/2012US20120190688 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/26/2012US20120190678 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
07/26/2012US20120190649 Bicyclic aryl sphingosine 1-phosphate analogs
07/26/2012US20120190634 Lipoteichoic acid-derived glycolipids, and compositions comprising same
07/26/2012US20120190619 Methods of identifying anti-inflammatory compounds
07/26/2012US20120190612 Methods of treatment
07/26/2012US20120189709 Method of using beta-hydroxy-beta-methylbutyrate to treat a condition
07/26/2012US20120189693 Oral dosage forms
07/26/2012US20120189689 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
07/26/2012US20120189688 Carrier component and fabrication method thereof
07/26/2012US20120189687 Compositions and Methods for Topical Application of Growth Factors and Cytokines
07/26/2012US20120189672 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
07/26/2012US20120189663 Method of producing a medical composition
07/26/2012US20120189662 Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti
07/26/2012US20120189660 Composition for Preventing or Treating Liver Diseases, Containing Plant Stem Cell Lines Derived from the Cambium of Panax Ginseng Including Mountain Ginseng or Ginseng as Active Ingredient
07/26/2012US20120189658 Chimeric Influenza Virus-Like Particles Comprising Hemagglutinin
07/26/2012US20120189657 Microbial vaccine and vaccine vector
07/26/2012US20120189655 Attenuated Live Vaccine for Prevention of Porcine Reproductive and Respiratory Syndrome
07/26/2012US20120189654 Vaccine
07/26/2012US20120189651 Active agent complex and formulation comprising the active agent complex
07/26/2012US20120189650 Immunogenic composition comprising variants of staphylococcal clumping factor a
07/26/2012US20120189648 Infectious hepatitis c viruses of genotype 3a and 4a and uses thereof
07/26/2012US20120189646 Novel compounds
07/26/2012US20120189645 Compositions and methods to treat and control tumors
07/26/2012US20120189642 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
07/26/2012US20120189639 Anti-gitr antibodies
07/26/2012US20120189626 Treatment of complement-associated disorders
07/26/2012US20120189621 Combination Therapies and Methods Using Anti-CD3 Modulating Agents and Anti-IL-6 Antagonists
07/26/2012US20120189615 CROSS-ß STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS-ß STRUCTURE, FOR MODULATING CROSS-ß STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS-ß STRUCTURE-MEDIATED TOXICITY
07/26/2012US20120189614 Inhibitors of filovirus entry into host cells
07/26/2012US20120189598 Oral nutritional supplement for children comprising probiotics
07/26/2012US20120189597 Nutritional compositions including exogenous nucleotides
07/26/2012US20120189583 Placental or umbilical cord tissue compositions